Publications by authors named "Haris Afridi"

Claim this Profile
S
Short-term function versus long-term stability: rethinking the role of suture-augmented ACL repair.
Fnu Shahzaib, Arifa Arifa, Haris Afridi, Raghabendra Kumar Mahato

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digoxin-induced ventricular fibrillation in undiagnosed Wolff-Parkinson-White syndrome: a clinical reminder - a letter to the editor.
Kashif Shahzad, Hajra Cheema, Atif Mahmood, Haris Afridi, Raghabendra Kumar Mahato

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tourniquets in snakebite: a harmful tradition needing urgent public education.
Haris Afridi, Muqadas Khosa, Raghabendra Kumar Mahato

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative anesthetic challenges in neuromyelitis optica: balancing safety and relapse risk with neurotechnology.
Summayya Anwar, Ali Hamza, Haris Afridi, Muhammad Talha, Suleman Khan

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new era in pain management: suzetrigine's role in reducing opioid dependence.
Umaid Khan, Haris Afridi, Raghabendra Kumar Mahato, Hammad Amin Mirza

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond CT and MRI: terahertz imaging as a frontier tool for early mesothelioma diagnosis.
Semil Saleem, Abdullah Imtiaz, Ubaid Ur Rehman, Muneeb Saifullah, Haris Afridi

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From surgery to immunotherapy: Papzimeos as the first FDA-approved therapy for recurrent respiratory papillomatosis (RRP).
Haris Afridi, Khola Qazi, Mariam Adnan Rizvi, Rida Nasir, Raghabendra Kumar Mahato

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desloratadine as an adjunct to isotretinoin: enhancing tolerability and adherence in acne management.
Khola Qazi, Mariam Adnan Rizvi, Rida Nasir, Haris Afridi, Raghabendra Kumar Mahato

Ann Med Surg (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Remodeling the Tumor Microenvironment via Metal-Phenolic Network-Coated Poly(lactic acid--glycolic acid) Nanoparticles for Inducing Multimodal Combination Therapy in Non-Small Cell Lung Cancer".
Haris Afridi, Muqadas Khosa

ACS Appl Bio Mater· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "A national survey of four decades of hereditary angioedema prophylaxis" - The emerging role of Garadacimab.
Haris Afridi, Kainat Afzal

Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Emergent role of complement inhibitors in myasthenic crisis - Complement for crisis, FcRn for continuity".
Haris Afridi, Kainat Afzal

Clin Neurol Neurosurg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clarifications Needed on Cystatin-C Units and Data Presentation in Makinde et al. Study on Pediatric CSA-AKI.
Fnu Shahzaib, Arifa Arifa, Haris Afridi

Ann Card Anaesth· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "selumetinib use as targeted therapy for plexiform neurofibroma: a comprehensive review of the literature" - mirdametinib as the emerging standard in NF1-PN.
Haris Afridi, Kainat Afzal, Fnu Shahzaib

Orbit· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis